{
  "cik": 1798749,
  "cik_padded": "0001798749",
  "entityName": "Jade Biosciences, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-096550",
      "filed": "2026-03-06",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 196000.0,
        "cash": 88438000.0,
        "eps_diluted": -3.19,
        "free_cash_flow": -94885000.0,
        "net_income": -127410000.0,
        "operating_cash_flow": -94689000.0,
        "operating_income": -113542000.0,
        "stockholders_equity": 332518000.0,
        "total_assets": 349781000.0,
        "total_liabilities": 17263000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0519159865029863,
        "roa_avg2y": -0.6030100809314213,
        "roa_period_end": -0.3642564919192295,
        "roe_avg2y": -0.8918552843878076,
        "roe_period_end": -0.38316722703733336
      }
    },
    {
      "accn": "0001558370-25-003750",
      "filed": "2026-03-06",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 69386000.0,
        "eps_diluted": -2.44,
        "net_income": -69628000.0,
        "operating_cash_flow": -71196000.0,
        "operating_income": -74596000.0,
        "stockholders_equity": -46799000.0,
        "total_assets": 72799000.0,
        "total_liabilities": 119596000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.695525354989836,
        "roa_period_end": -0.9564417093641395,
        "roe_avg2y": -2.22251304722537
      }
    },
    {
      "accn": "0001558370-25-003750",
      "filed": "2025-03-27",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 142000.0,
        "cash": 23491000.0,
        "eps_diluted": -2.87,
        "free_cash_flow": -56920000.0,
        "net_income": -75521000.0,
        "operating_cash_flow": -56778000.0,
        "operating_income": -81409000.0,
        "stockholders_equity": 109456000.0,
        "total_assets": 127418000.0,
        "total_liabilities": 17962000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.16410247039906448,
        "roa_avg2y": -0.5749184489892242,
        "roa_period_end": -0.5927027578521088,
        "roe_avg2y": -0.6394692610891664,
        "roe_period_end": -0.6899667446279785
      }
    },
    {
      "accn": "0001798749-24-000015",
      "filed": "2025-03-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 195000.0,
        "cash": 22397000.0,
        "eps_diluted": -2.1,
        "free_cash_flow": -39317000.0,
        "net_income": -51511000.0,
        "operating_cash_flow": -39122000.0,
        "operating_income": -53237000.0,
        "stockholders_equity": 126743000.0,
        "total_assets": 135301000.0,
        "total_liabilities": 8558000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06752246672400054,
        "roa_avg2y": -0.33161872634099865,
        "roa_period_end": -0.3807141114995455,
        "roe_avg2y": -0.34436975407890735,
        "roe_period_end": -0.4064208674246309
      }
    },
    {
      "accn": "0001798749-24-000015",
      "filed": "2024-03-25",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 181000.0,
        "cash": 54197000.0,
        "eps_diluted": -1.87,
        "free_cash_flow": -27580000.0,
        "net_income": -22963000.0,
        "operating_cash_flow": -27399000.0,
        "operating_income": -23022000.0,
        "stockholders_equity": 172418000.0,
        "total_assets": 175363000.0,
        "total_liabilities": 2945000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.017080583233769098,
        "roa_avg2y": -0.2550339297415564,
        "roa_period_end": -0.13094552442647536,
        "roe_avg2y": -0.28870839986421415,
        "roe_period_end": -0.13318215035553133
      }
    },
    {
      "accn": "0001798749-23-000015",
      "filed": "2023-03-29",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 4573000.0,
        "net_income": -9611000.0,
        "operating_cash_flow": -7859000.0,
        "operating_income": -8889000.0,
        "stockholders_equity": -13344000.0,
        "total_assets": 4715000.0,
        "total_liabilities": 1774000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 1.1315712015070347
      }
    },
    {
      "accn": "0001493152-22-008189",
      "filed": "2022-03-30",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -3643000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-096550",
    "filed": "2026-03-06",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001798749.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001798749.json"
  },
  "ticker": "JBIO"
}